Masimo Corporation

NASDAQ:MASI

Medical - Devices

Healthcare
$179.95 +0.00%

+$0.00 today

Market cap
$9.42B
Beta
1.10
P/E (TTM)
123.1
EPS (TTM)
$1.46
52W Low $125.94High $179.99

Volume 0.00M

Average 1.08M

MASI Net Income

Bottom-line profit, the starting point for calculating cash from operations.

Masimo CorporationNASDAQ: MASI

Net Income · Q1 FY2026 · quarter ended Apr 2026

Net income grows, but more slowly than its trailing trend

Q1 FY2026 net income of $56.3M rose 19.3% year over year, behind the +325.2% change in trailing-twelve-month net income. Sequentially, it fell 88.7% from the prior quarter.

Context

  • Net income amounted to 9.9% of revenue in FY2025, down 4.6 pp from a year earlier.
  • Net income increased in 1 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 2 analysts of $319.86M (+311.1%) for the fiscal year ending Jan 2027, a step up from the -50.3% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterApr 2026
$56.3M-88.7% QoQ
Last fiscal yearJan 2026
-$151.5M-50.3% YoY
LTMApr 2026
$652.6M+325.2% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+19.3%+67.8%+48.5 pp
1 year-50.3%+311.1%+361.4 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
(151.5M) USD
Year-over-year change
+50.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How MASI compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +325.2% is the 2nd highest of 11, against a peer median of +3.1%.
  • Net income amounts to 41.9% of revenue for MASI, versus a peer median of 7.8%.
MASI Competitors
Net Income for MASI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BAXBaxter International Inc.LTM Jun 2026$975M USD+304.6%-32.5%8.5%
MASIMasimo CorporationLTM Apr 2026$652.6M USD+325.2%—41.9%
AVTRAvantor, Inc.LTM Jun 2026$578M USD-184.1%—8.8%
HSICHenry Schein, Inc.LTM Jun 2026$424M USD+5.5%-11.1%3.1%
ABVXAbivax S.A.FY2025€322.84M EUR+83.2%+74.5%—
ATRAptarGroup, Inc.LTM Jun 2026$307.89M USD-21.3%+17.9%7.8%
RYTMRhythm Pharmaceuticals, Inc.LTM Sep 2026$193.81M USD+0.8%+2.8%69.0%
STVNStevanato Group S.p.A.LTM Jun 2026€173.64M EUR-3.3%-10.5%14.2%
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$162.3M USD+36.7%—6.3%
MOHMolina Healthcare, Inc.LTM Sep 2026$48M USD-105.4%-15.8%0.1%
RGENRepligen CorporationLTM Jun 2026$41.54M USD+400.4%-35.9%5.3%
Peer median (excluding MASI) —+3.1%-10.8%7.8%

Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Net Income229.6M143.5M81.5M(304.9M)(151.5M)
Depreciation & Amortization35.6M136.1M98.3M103M38.8M
Deferred Income Tax(15.1M)(39.3M)(35.6M)(38.2M)11.8M
Stock-Based Compensation44.7M47.7M7M41.5M35.8M
Change in Working Capital(31.5M)(261.8M)(70.9M)(10.7M)(89.9M)
Accounts Receivables(76.9M)(151.3M)91.9M(60.2M)17.2M
Inventory13.5M(155.9M)(69.2M)(7.5M)(112.1M)
Accounts Payables11M60.5M(19.6M)14.8M(27.1M)
Other Working Capital20.9M(15.1M)(74M)42.2M32.1M
Other Non-Cash Items1.3M3.2M13.8M405.7M372.2M
Operating Cash Flow264.6M29.4M94.1M196.4M217.2M
Capital Expenditures(34.9M)(56.3M)(87.7M)(51.1M)(19.4M)
Acquisitions (Net)0(999.7M)7.5M00
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(12M)(5.2M)(44.7M)(31.2M)294.5M
Investing Cash Flow(37.5M)(1.06B)(81.2M)(51.2M)275.1M
Debt Repayment0939.2M(51.2M)(146.8M)(207.8M)
Common Stock Issued23.2M8.1M7M25.2M71.4M
Common Stock Repurchased(128.9M)(401.5M)00(363.7M)
Dividends Paid00000
Other Financing Activities(16.7M)(25.4M)(12.9M)(4M)(20.6M)
Financing Cash Flow(122.4M)520.4M(57.1M)(125.6M)(520.7M)
Effect of Forex Changes(1.3M)(30.9M)2.8M(6.4M)53.8M
Net Change in Cash103.4M(538.8M)(41.4M)13.2M26M
Free Cash Flow229.7M(26.9M)6.4M145.3M197.8M

Masimo Corporation

NASDAQ:MASI

Intrinsic Alpha fair value

Locked

Current Price

$179.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.